Emile A. Battat
Net Worth

Last updated:

What is Emile A. Battat net worth?

The estimated net worth of Mr. Emile A. Battat is at least $24,146,845 as of 1 Jul 2024. He has earned $11,785,045 from insider trading and has received compensation worth at least $12,361,800 in Atrion Corporation.

What is the salary of Emile A. Battat?

Mr. Emile A. Battat salary is $618,090 per year as Executive Chairman in Atrion Corporation.

How old is Emile A. Battat?

Mr. Emile A. Battat is 87 years old, born in 1938.

What stocks does Emile A. Battat currently own?

As insider, Mr. Emile A. Battat owns shares in one company:

Company Title Shares Price per share Total value
Atrion Corporation (ATRI) Executive Chairman 149,802 $0 $0

What does Atrion Corporation do?

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Emile A. Battat insider trading

Atrion Corporation

Mr. Emile A. Battat has made 37 insider trades between 2005-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 75,000 units of ATRI stock on 27 Apr 2005. As of 1 Jul 2024 he still owns at least 149,802 units of ATRI stock.

Transaction Date Security Shares Price per share Total value Source
Option
restricted stock units 310 N/A N/A
Option
common stock 310 N/A N/A
Option
restricted stock units 310 N/A N/A
Option
common stock 310 N/A N/A
Option
Stock Options 2,000 $464.05 $928,100
Option
Common Stock 4,000 $464.05 $1,856,200
Option
Stock Options 2,000 $464.05 $928,100
Sale
Common Stock 3 $713 $2,139
Sale
Common Stock 101 $683 $68,983
Sale
Common Stock 100 $683.49 $68,349
Sale
Common Stock 60 $684.13 $41,048
Option
Common Stock 6,000 $464.05 $2,784,300
Option
Common Stock 12,000 N/A N/A
Option
Common Stock 6,000 N/A N/A
Purchase
Common Stock 1,000 N/A N/A
Sale
Common Stock 1,208 N/A N/A
Sale
Common Stock 200 $651.75 $130,350
Sale
Common Stock 100 $585.5 $58,550
Sale
Common Stock 198 $589 $116,622
Sale
Common Stock 200 $587 $117,400
Sale
Common Stock 1,100 $581 $639,100
Sale
Common Stock 617 $574.57 $354,510
Sale
Common Stock 100 $576 $57,600
Sale
Common Stock 100 $546.5 $54,650
Sale
Common Stock 555 $546.25 $303,169
Sale
Common Stock 135 $540 $72,900
Sale
Common Stock 225 $540.25 $121,556
Sale
Common Stock 361 $545.13 $196,790
Option
Common Shares 25,000 $181.44 $4,536,000
Option
Stock Options 25,000 $181.44 $4,536,000
Sale
Common Shares 900 $468.5 $421,650
Sale
Common Shares 500 $463.05 $231,525
Sale
Common Shares 1,593 $460.8 $734,054
Sale
Common Shares 132 $444.73 $58,704
Sale
Common Shares 70 $443.3 $31,031
Sale
Common Shares 900 $442.92 $398,628
Sale
Common Shares 12 $432 $5,184
Sale
Common Shares 72 $427.5 $30,780
Sale
Common Shares 665 $429 $285,285
Sale
Common Shares 426 $429 $182,754
Sale
Common Shares 130 $427 $55,510
Sale
Common Shares 3,000 $423.5 $1,270,500
Sale
Common Stock 5,204 $291.05 $1,514,624
Sale
Common Shares 3,000 $239.85 $719,535
Sale
Common Shares 2,414 $239.5 $578,153
Sale
Common Shares 2,386 $239.5 $571,447
Sale
Common Shares 200 $241.72 $48,344
Option
Common Shares 6,250 $71.86 $449,125
Option
Stock Options 6,250 $71.86 $449,125
Sale
Common Stock 6,000 $159.08 $954,450
Sale
Common Stock 4,000 $161.73 $646,920
Option
Stock Options 18,750 $71.86 $1,347,375
Option
Common Stock 18,750 $71.86 $1,347,375
Option
Common Shares 17,800 $44.58 $793,524
Option
Stock Options 17,800 $44.58 $793,524
Sale
Common Shares 7,000 $91.75 $642,250
Option
Common Shares 2,200 $44.31 $97,482
Option
Stock Options 2,200 $44.31 $97,482
Option
Stock Options 75,000 $17.92 $1,344,000
Option
Common Shares 75,000 $17.92 $1,344,000

Atrion key executives

Atrion Corporation executives and other stock owners filed with the SEC: